ADVB Advanced Biomed Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q May 15, 2026
$6.73
· of 52w range
· above low
· to high
$3.6152w low
$24.2352w high
Market Cap (MRQ)
$9M
P/E
-2.1
EPS
$-0.16
your badges
52W Range
$4–$24
Analyst Rating
·
Price Target
·
P/E
-2.1
ROE
-159.1%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ADVB Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.73
Market Cap (MRQ)
$9M
P/E
-2.1
EPS
$-0.16
ROE
-159.1%
52W Range
$4–$24
ADVB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Feb. 20, 2026 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-0.162024-06-30 → 2025-06-30
Free Cash Flow$-6M2025-06-30 → 2025-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ADVB | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -2.1 | · | · | · | |
| P/B (MRQ) | 1.0 | · | 0.8 | Undervalued | |
| Price / FCF (TTM) | -3.2 | · | · | · | |
| Price / Cash Flow (TTM) | -3.2 | · | · | · | |
| Price / Tangible Book | 2.1 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ADVB | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -59.4% | · | -59.4% | In line | |
| ROE | -159.1% | · | -159.1% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ADVB | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 7.4 | · | 3.5 | Strong liquidity | |
| Quick Ratio | 1.0 | · | 2.1 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Next Report
Oct 06, 2026
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $909.8K | · | |
| SG&A Expense | $2M | · | |
| Operating Expenses | $3M | · | |
| Interest Income | $24.9K | · | |
| Other Non-op | $-262.8K | · | |
| Pretax Income | $-3M | · | |
| Net Income | $-3M | · | |
| EPS (Basic) | $-0.16 | · | |
| EPS (Diluted) | $-0.16 | · | |
| Shares (Basic) | 20,525,699 | · | |
| Shares (Diluted) | 20,525,699 | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $3M | · | |
| Prepaid Expense | $2M | · | |
| Current Assets | $13M | · | |
| PP&E (Net) | $125.2K | · | |
| PP&E (Gross) | $1M | · | |
| Accum. Depreciation | $1M | · | |
| Other Non-current Assets | $2.6K | · | |
| Total Assets | $14M | · | |
| Accounts Payable | $358.2K | · | |
| Accrued Liabilities | $575.8K | · | |
| Current Liabilities | $10M | · | |
| Capital Leases | $5.9K | · | |
| Total Liabilities | $10M | · | |
| Common Stock | $1.1K | · | |
| Retained Earnings | $-19M | · | |
| AOCI | $1M | · | |
| Stockholders' Equity | $3M | $619.0K | |
| Liabilities + Equity | $14M | · | |
| Shares Outstanding | 1,082,000 | 20,000,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $343.8K | · | |
| Operating Cash Flow | $-6M | · | |
| CapEx | $31.6K | · | |
| Investing Cash Flow | $-31.6K | · | |
| Financing Cash Flow | $6M | · | |
| Net Change in Cash | $295.9K | · | |
| Free Cash Flow | $-6M | · |
Profitability
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| ROA | -59.4% | · | |
| ROE | -159.1% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.1 | · | |
| Quick Ratio | 1.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Book Value / Share | $0.16 | · | |
| Cash Flow / Share | $-0.28 | · | |
| Cash / Share | $0.13 | · | |
| EPS (TTM) | $-0.16 | $-0.12 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-3M | $-2M | |
| Market Cap | $15M | · | |
| P/E | -4.4 | · | |
| P/B | 4.4 | · | |
| P / Tangible Book | 4.4 | · | |
| P / Cash Flow | -2.6 | · | |
| P / FCF | -2.6 | · | |
| Earnings Yield | -22.9% | · |
Income Statement
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $243.2K | $186.3K | $236.0K | $265.2K | $220.0K | $212.4K | $181.7K | $209.1K | $313.5K | $188.4K | |
| SG&A Expense | $276.6K | $210.3K | $287.9K | $1M | $347.5K | $67.7K | $338.3K | $495.5K | $431.9K | $462.9K | |
| Operating Expenses | $519.8K | $396.6K | $523.9K | $1M | $567.5K | $280.1K | $520.0K | $704.6K | $745.4K | $651.3K | |
| Interest Income | · | $9.2K | $448 | $9.5K | · | $15.4K | $10 | $33.4K | $104 | $20.0K | |
| Other Non-op | $31.0K | $42.9K | $136.6K | $418.7K | $-630.0K | $-314.8K | $254.4K | $-138.2K | $-310.9K | $486.0K | |
| Pretax Income | $-488.9K | $7M | $-386.9K | $-1M | $-1M | $-579.5K | $-265.6K | $-809.4K | $-1M | $-145.3K | |
| Net Income | $-488.9K | $7M | $-386.9K | $-701.6K | $-1M | $-907.9K | $-265.6K | $-809.4K | $-1M | $-145.3K | |
| EPS (Basic) | $-0.38 | $0.31 | $-0.02 | $-0.03 | $-1.35 | $-0.05 | $-0.01 | $-0.04 | $-0.05 | $-0.01 | |
| EPS (Diluted) | $-0.38 | $0.31 | $-0.02 | $-0.03 | $-1.35 | $-0.05 | $-0.01 | $-0.04 | $-0.05 | $-0.01 | |
| Shares (Basic) | 1,284,923 | 21,640,000 | 21,640,000 | · | 1,023,955 | 20,000,000 | 20,000,000 | · | 20,000,000 | 20,000,000 | |
| Shares (Diluted) | 1,284,923 | 21,640,000 | 21,640,000 | · | 1,023,955 | 20,000,000 | 20,000,000 | · | 20,000,000 | 20,000,000 |
Balance Sheet
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $3M | $3M | $3M | $5M | $3M | · | $3M | · | · | |
| Prepaid Expense | $8M | $8M | $3M | $3M | $3M | $481.7K | · | $443.1K | · | · | |
| Current Assets | $11M | $11M | $6M | $6M | $8M | $3M | · | $3M | · | · | |
| PP&E (Net) | $87.3K | $97.1K | $281.3K | $331.3K | $355.3K | $401.0K | · | $524.5K | · | · | |
| PP&E (Gross) | $1M | $1M | $2M | $2M | $2M | $2M | · | $2M | · | · | |
| Accum. Depreciation | $961.8K | $973.4K | $2M | $2M | $1M | $1M | · | $1M | · | · | |
| Intangibles | · | · | · | · | $20.3K | $50.5K | · | $119.0K | · | · | |
| Other Non-current Assets | $2.2K | $956 | $74.8K | $83.0K | · | · | · | · | · | · | |
| Total Assets | $11M | $11M | $6M | $7M | $8M | $5M | · | $4M | · | · | |
| Accounts Payable | $377.3K | $369.3K | $641.6K | $632.7K | $618.5K | $617.9K | · | $620.5K | · | · | |
| Accrued Liabilities | $238.5K | $224.0K | · | · | · | · | · | · | · | · | |
| Current Liabilities | $1M | $1M | $3M | $3M | $4M | $4M | · | $3M | · | · | |
| Capital Leases | $10.9K | $1.4K | $2.9K | $5.9K | $44.5K | $56.3K | · | $64.5K | · | · | |
| Total Liabilities | $1M | $1M | $3M | $3M | $4M | $4M | · | $3M | · | · | |
| Common Stock | $1.4K | $21.6K | $21.6K | $21.6K | $21.6K | $20.0K | · | $20.0K | · | · | |
| Retained Earnings | $-13M | $-13M | $-20M | $-19M | $-19M | $-17M | · | $-16M | · | · | |
| AOCI | $843.8K | $874.7K | $1M | $1M | $1M | $1M | · | $1M | · | · | |
| Stockholders' Equity | $9M | $9M | $3M | $3M | $4M | $619.0K | · | $2M | · | · | |
| Liabilities + Equity | $11M | $11M | $6M | $7M | $8M | $5M | · | $4M | · | · | |
| Shares Outstanding | 1,382,133 | 21,640,000 | 21,640,000 | 21,640,000 | 21,640,000 | 20,000,000 | · | 20,000,000 | · | · |
Cash Flow
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9.3K | $-12.9K | $48.0K | $64.4K | $78.1K | $-56.8K | $102.2K | $153.9K | $83.0K | · | |
| Amort. of Intangibles | · | · | · | · | $30.2K | $33.6K | · | · | $31.9K | $31.7K | |
| Operating Cash Flow | $-239.8K | $-513.6K | $-610.3K | $-2M | $-3M | $-841.8K | $-29.7K | $-475.8K | $-1M | · | |
| CapEx | $1.3K | $12.9K | $1.8K | $20.1K | $2.2K | $-10.7K | $20.0K | $53.3K | $-26.7K | · | |
| Investing Cash Flow | $-1.3K | $-12.9K | $-1.8K | $-20.1K | $-2.2K | $10.7K | $-20.0K | $-53.3K | $26.7K | · | |
| Financing Cash Flow | $268.3K | $315.5K | $447.5K | $-765.5K | $6M | $408.3K | $392.5K | $323.5K | $562.2K | · | |
| Net Change in Cash | $-2.0K | $-45.9K | $-247.4K | $-2M | $3M | $10.2K | $39.0K | $-55.7K | $-112.9K | · | |
| Free Cash Flow | · | · | $-612.1K | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -5.2% | 89.3% | -12.4% | · | -33.4% | · | · | · | · | · | |
| ROE | -7.3% | 135.8% | -25.8% | · | -67.0% | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.4 | 8.6 | 1.9 | · | 1.9 | · | · | · | · | · | |
| Quick Ratio | · | 2.1 | 0.9 | · | 1.3 | · | · | · | · | · |
Per Share
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.66 | $0.44 | $0.14 | · | $0.19 | · | · | · | · | · | |
| Cash Flow / Share | · | · | $-0.03 | · | · | · | · | · | · | · | |
| Cash / Share | · | $0.12 | $0.12 | · | $0.24 | · | · | · | · | · | |
| EPS (TTM) | $-0.12 | $-1.09 | $-1.45 | · | $-1.45 | $-0.15 | $-0.11 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $5M | $4M | $-3M | · | $-3M | $-3M | $-2M | · | · | · | |
| Market Cap | $6M | $6M | $10M | · | $85M | · | · | · | · | · | |
| P/E | -38.0 | -5.4 | -6.2 | · | -54.1 | · | · | · | · | · | |
| P/B | 0.7 | 0.7 | 3.2 | · | 20.5 | · | · | · | · | · | |
| P / Tangible Book | 0.7 | 0.7 | 3.2 | · | 20.6 | · | · | · | · | · | |
| P / Cash Flow | · | · | -15.9 | · | · | · | · | · | · | · | |
| Earnings Yield | -2.6% | -18.7% | -16.2% | · | -1.8% | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Net Income | $-3M | $-3M |
| Diluted EPS | $-0.16 | $-0.14 |
| Metric | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Current Ratio | 2.1 | · |
| Quick Ratio | 1.0 | · |
| Metric | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Free Cash Flow | $-6M | · |
Institutional owners (13F)
Institutional activity — Q4 2025 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 (-2 vs prior Q) | 2 (+1 vs prior Q) | 1 (-1 vs prior Q) | 2 (+1 vs prior Q) | -219K |
Compared to Q3 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Company insiders 1 insider · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Hung To Pau | 10% owner | July 27, 2026 J | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed May 15, 2026